Analysis of multiple glioblastoma-related datasets from GEO demonstrated a positive correlation between MAD2L2 expression and the MYC pathway (Fig. 7B), indicating that MAD2L2 may influence glioma growth and stemness by affecting c-MYC activity. Here, MAD2L2 is linked to central nervous system cancer.